Approval · Notice of Compliance 30810 · 2023
BRUKINSA: Notice of Compliance 30810
Issued May 24, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30810
- Date
- May 24, 2023
- Company
- Beigene Switzerland Gmbh
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRUKINSA | Not yet assigned | — |
Medicinal ingredients
- ZANUBRUTINIB 80 MG per CAP